PLRX vs SO · $77.3M cap vs P/E 22, rev $29.55B
Pliant Therapeutics Inc (PLRX) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
PLRX currently screens at market cap $77.3M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the PLRX and SO stock pages for the full models.
Not investment advice.